Global strategy in the treatment of HIV infection in 2022

Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):34-36. doi: 10.37201/req/s03.08.2022. Epub 2022 Oct 24.

Abstract

The treatment of HIV infection has become a cornerstone for the global control of the pandemic due to its benefits on individual health and for preventing the transmission of HIV. It should be started in all people with HIV infection and as quickly as possible. Ideally, it should be started on the same day of diagnosis or, failing that, within the first 7 days. Antiretroviral regimens with excellent efficacy, no significant toxicity, and convenient administration are currently available for initiation of antiretroviral treatment. They can incorporate two or three drugs and are always based on a second-generation integrase inhibitor.

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • HIV Infections* / prevention & control
  • HIV Integrase Inhibitors* / therapeutic use
  • Humans

Substances

  • Anti-Retroviral Agents
  • HIV Integrase Inhibitors
  • Anti-HIV Agents